Celia R. Berkers
- Molecular Biology top 2%
- Oncology top 2%
- Cancer Research top 1%
- Immunology top 5%
- Hematology top 1%
- Co-authors
- Huib OvaaEsther A. ZaalKaren H. VousdenOliver D.K. MaddocksHidde L. PloeghSusan MasonLiang ZhengEyal Gottlieb
- Topics
- Ubiquitin and proteasome pathways (24 papers)Peptidase Inhibition and Analysis (12 papers)Protein Degradation and Inhibitors (12 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Celia R. Berkers
74 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 3.9k
- Oncology 1.4k
- Cancer Research 1.2k
- Immunology 714
- Hematology 688
Countries citing papers authored by Celia R. Berkers
This map shows the geographic impact of Celia R. Berkers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celia R. Berkers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celia R. Berkers more than expected).
Fields of papers citing papers by Celia R. Berkers
This network shows the impact of papers produced by Celia R. Berkers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celia R. Berkers. The network helps show where Celia R. Berkers may publish in the future.
Co-authorship network of co-authors of Celia R. Berkers
This figure shows the co-authorship network connecting the top 25 collaborators of Celia R. Berkers. A scholar is included among the top collaborators of Celia R. Berkers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celia R. Berkers. Celia R. Berkers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 10 | |
| 5 | 3 | |
| 6 | 5 | |
| 7 | 6 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 11 | |
| 11 | 15 | |
| 12 | 50 | |
| 13 | 48 | |
| 14 | 117 | |
| 15 | 55 | |
| 16 | 110 | |
| 17 | 24 | |
| 18 | 19 | |
| 19 | 163 | |
| 20 | 70 |
About Celia R. Berkers
Celia R. Berkers is a scholar working on Cancer Research, Oncology and Hematology, having authored 76 papers that have together received 5.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (24 papers), Peptidase Inhibition and Analysis (12 papers) and Protein Degradation and Inhibitors (12 papers). The work is most often cited by research in Cancer Research (1.2k citations), Hematology (688 citations) and Molecular Biology (3.9k citations). Celia R. Berkers has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Huib Ovaa, Esther A. Zaal, Karen H. Vousden, Oliver D.K. Maddocks, Hidde L. Ploegh, Susan Mason, Liang Zheng, Eyal Gottlieb, Karen Blyth and M. Groll. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.